What is the long-term outlook for the Bruins?

With the 2019-20 NHL season on hold we are going to review where each NHL team stands at this moment until the season resumes. Here we take a look at the long-term outlook for the Boston Bruins.

Pending Free Agents

The Core

The Bruins have two big things going for them to maintain a pretty big window for Stanley Cup contention.

The most important is that they have a great core of talent to build around in David Pastrnak, Patrice Bergeron, Brad Marchand, Charlie McAvoy, David Krejci, and Brandon Carlo.

Along with that is the fact they have a significant portion of their team signed long-term on deals that not only have term, but are also below market value. Nobody on the team carries a salary cap hit of greater than $7.25 million (Krejci) while only two players (Krejci and starting goalie Tuukka Rask) count for more than $7 million against the cap in a single season.

The quartet of Marchand, Bergeron, Pastrnak, and McAvoy, for example, takes up less than $25 million in salary cap space per season through the end of the 2021-22 season. That not only keeps a tremendous group of players together, it gives the team the type of salary cap flexibility it needs to build a powerhouse team around them. The Bruins have done exactly that.

Their big challenges this offseason are going to be re-signing UFA defenseman Torey Krug — one of their top blue-liners — and securing a new contract for restricted free agent forward Jake DeBrusk, currently one of their top complementary players. Because they are getting such bargains at the top of their lineup they should have the salary cap space to make it work.

Krug will definitely be the biggest challenge (especially if there is pressure to keep him around the $6.5 million mark that everyone else in their core currently makes) but there is room.

Long-term needs

It might seem like an outrageous thing to say right now given the way the team is built, but it is really tempting to put goaltending as a long-term question.

Right now the duo of Tuukka Rask and Jaroslav Halak is as good as it gets in the NHL. They are both outstanding and capable of being No. 1 starters in the league, while Rask has been one of the league’s elites for most of his career. But there is some uncertainty beyond this season. For one, Halak is one of the Bruins’ biggest unrestricted free agents after this season so there is no guarantee that he returns. But there is also the fact that Rask recently hinted at the possibility of potentially retiring after next season (via the Boston Globe). Still a lot of unknowns there and a situation to keep an eye on in the future.

Beyond that, depth might be the other big long-term issue.

If they are unable to re-sign Krug that would love a pretty massive hole on their blue line, and there is going to come a point where Zdeno Chara is no longer part of this team. That is half of your top-four and would be an awful lot to replace at one time if neither one is there beyond this season.

Long-term strengths

It kind of relates to everything mentioned in the core part, but they have some of the league’s best players at forward signed for multiple seasons at below market contracts.

The trio of Pastrnak-Bergeron-Marchand is one of the best lines in the entire league. Individually, they are all among the top-20 players in the league. Together, they are almost unstoppable.

On the blue line, McAvoy and Carlo are both already outstanding defensemen and are just now starting to hit their prime years in the NHL.

Basically, the Bruins have the most important pieces for sustained success already in place (superstar forwards and young top-pairing defensemen), have them all signed long-term, and they are mostly at points in their career where they should still have several elite seasons ahead of them. The Bruins have been one of the league’s top-four teams for three years in a row now and there is no sign that they are going to drop off from that level anytime soon.

 

MORE:
• Looking at the 2019-20 Boston Bruins
Bruins surprises and disappointments

Adam Gretz is a writer for Pro Hockey Talk on NBC Sports. Drop him a line at phtblog@nbcsports.com or follow him on Twitter @AGretz.

Scroll Down For: